Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Oral CCX-872 is well tolerated in healthy volunteers

July 22, 2013

Nymox reports data from pivotal trial of NX-1207

July 15, 2013

ProMetic set to advance lead antifibrotic drug candidate PBI-4050 to clinic

July 12, 2013

CRUISE-1 phase III trial of iron-delivery drug SFP meets primary endpoint

July 12, 2013

La Jolla Pharmaceutical begins dosing in phase II trial of GCS-100 in chronic kidney disease

July 9, 2013

Pharmaxis and University of Sydney receive Australian Research Council grants

July 8, 2013

Phase II trial of AQX-1125 in interstitial cystitis/bladder pain syndrome is under way

July 8, 2013

Vivus obtains European approval for avanafil

June 27, 2013

Mesoblast receives approval for trial of mesenchymal precursor cells

June 27, 2013

Anthera Pharmaceuticals begins phase II BRIGHT-SC study in IgA nephropathy

June 26, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...